Toshiaki Kawaguchi

Aomori, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 34 publications

Long-term disease control after upfront chemotherapy and surgery in a patient with primary prostate leiomyosarcoma.

Long-term disease control after upfront chemotherapy and surgery in a patient with primary prostate leiomyosarcoma.

Journal: IJU case reports

Published: September 12, 2021

Therapeutic effects of the combined androgen blockade therapy versus luteinizing hormone-releasing hormone analog monotherapy in patients with hormone naïve metastatic prostate cancer: a multi-institutional comparative analysis.

Therapeutic effects of the combined androgen blockade therapy versus luteinizing hormone-releasing hormone analog monotherapy in patients with hormone naïve metastatic prostate cancer: a multi-institutional comparative analysis.

Journal: Translational andrology and urology

Published: February 03, 2021

Impact of pretreatment anemia on upfront abiraterone acetate therapy for metastatic hormone-sensitive prostate cancer: a multicenter retrospective study.

Impact of pretreatment anemia on upfront abiraterone acetate therapy for metastatic hormone-sensitive prostate cancer: a multicenter retrospective study.

Journal: BMC cancer

Published: October 08, 2020

Prognostic significance of the Ki67 index and programmed death-ligand 1 expression after radical cystectomy in patients with muscle-invasive bladder cancer.

Prognostic significance of the Ki67 index and programmed death-ligand 1 expression after radical cystectomy in patients with muscle-invasive bladder cancer.

Journal: Urologic oncology

Published: September 05, 2020

Comparison of nivolumab plus ipilimumab with tyrosine kinase inhibitors as first-line therapies for metastatic renal-cell carcinoma: a multicenter retrospective study.

Comparison of nivolumab plus ipilimumab with tyrosine kinase inhibitors as first-line therapies for metastatic renal-cell carcinoma: a multicenter retrospective study.

Journal: International journal of clinical oncology

Published: July 11, 2020

Efficacy and safety of first-line nivolumab plus ipilimumab in patients with metastatic renal cell carcinoma: A multicenter retrospective study.

Efficacy and safety of first-line nivolumab plus ipilimumab in patients with metastatic renal cell carcinoma: A multicenter retrospective study.

Journal: International journal of urology : official journal of the Japanese Urological Association

Published: May 18, 2020

Frailty is significantly associated with the type of urinary diversion in patients with muscle-invasive bladder cancer.

Frailty is significantly associated with the type of urinary diversion in patients with muscle-invasive bladder cancer.

Journal: International journal of urology : official journal of the Japanese Urological Association

Published: February 03, 2020

Association of tumor burden with the eligibility of upfront intensification therapy in metastatic castration-sensitive prostate cancer: A multicenter retrospective study.

Association of tumor burden with the eligibility of upfront intensification therapy in metastatic castration-sensitive prostate cancer: A multicenter retrospective study.

Journal: International journal of urology : official journal of the Japanese Urological Association

Published: January 07, 2020

Clinical outcomes and prognostic factors in patients with newly diagnosed metastatic prostate cancer initially treated with androgen deprivation therapy: a retrospective multicenter study in Japan.

Clinical outcomes and prognostic factors in patients with newly diagnosed metastatic prostate cancer initially treated with androgen deprivation therapy: a retrospective multicenter study in Japan.

Journal: International journal of clinical oncology

Published: November 06, 2019

Multicenter prospective study validating the efficacy of a quantitative assessment tool for frailty in patients with urological cancers.

Multicenter prospective study validating the efficacy of a quantitative assessment tool for frailty in patients with urological cancers.

Journal: Medical oncology (Northwood, London, England)

Published: July 23, 2019

The Effect of Treatment Sequence on Overall Survival for Men With Metastatic Castration-resistant Prostate Cancer: A Multicenter Retrospective Study.

The Effect of Treatment Sequence on Overall Survival for Men With Metastatic Castration-resistant Prostate Cancer: A Multicenter Retrospective Study.

Journal: Clinical genitourinary cancer

Published: July 17, 2019

Validation of the IMDC Prognostic Model in Patients With Metastatic Renal-Cell Carcinoma Treated With First-Line Axitinib: A Multicenter Retrospective Study.

Validation of the IMDC Prognostic Model in Patients With Metastatic Renal-Cell Carcinoma Treated With First-Line Axitinib: A Multicenter Retrospective Study.

Journal: Clinical genitourinary cancer

Published: April 06, 2019

Showing 1-12 of 34

Last Updated: 09/26/2026